IIT Roorkee Develops Antibody-Discovery Platform

IIT Roorkee Develops Antibody-Discovery Platform

On 21 January 2026, the Indian Institute of Technology (IIT) Roorkee in Uttarakhand announced a next-generation antibody-discovery platform based on a high-diversity library of single-domain antibodies, also known as nanobodies.

Platform and intended applications

The platform is designed to enable rapid identification of antibodies against a range of targets, including infectious diseases, cancer, autoimmune disorders and emerging pathogens.

Research collaboration with Imgenex India

IIT Roorkee signed a Memorandum of Understanding (MoU) with Imgenex India Private Limited to support collaborative research, technology transfer and antibody-based applications. The collaboration covers antibody engineering, diagnostics, therapeutics and bioprocessing.

Important Facts for Exams

  • VHH and VNAR forms: Nanobodies derived from camelid heavy-chain antibodies are called VHH fragments; cartilaginous-fish IgNAR antibodies yield VNAR fragments.
  • Access to hidden targets: The extended CDR3 loop of camelid and fish nanobodies can penetrate buried antigen sites, including enzyme active sites inaccessible to whole antibodies.
  • Tissue penetration and clearance: Nanobodies’ low molecular mass can aid tissue penetration, but their renal elimination also gives them a short plasma half-life.
Originally written on January 21, 2026 and last modified on November 19, 2026.
Tags: , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *